• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

SHS sells Puracon to IK-backed Klingel

  • Harriet Matthews
  • Harriet Matthews
  • 02 December 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Life-sciences-focused investor SHS has sold its stake in medical technology packaging business Puracon to precision machining business Klingel Medical Metal, a portfolio company of IK Investment Partners.

The deal is intended to expand Klingel's offering for medical technology customers, building on the synergies shared by both companies.

The deal is Klingel's third add-on during IK's investment period. The company now employs 600 staff, compared with 300 employees in 2018.

Puracon

  • DEAL:

    Exit

  • LOCATION:

    Rosenheim

  • SECTOR:

    Medical equipment

  • FOUNDED:

    2003

  • TURNOVER:

    <€10m

  • STAFF:

    70

  • VENDOR:

    SHS

IK acquired Klingel in 2018 via an SBO from Halder, investing via IK VIII, which held a final close in 2016 on €1.85bn and deploys equity tickets of €50-150m. Debt was provided by a consortium of LBBW, SEB and Siemens.

SHS acquired a majority stake in Puracon in 2015. The GP invested via SHS IV Fonds, which held a final close on €125m in May 2015, exceeding its €100m target. The fund makes both minority and majority investments, focusing exclusively on life sciences and medical technology.

Asked about the investment in Puracon, Sascha Alilovic, managing partner at SHS, told Unquote: "We knew Puracon for a while before we invested, we liked the positioning of the company, including the fact that it was part of the process chain for sterile implants, although we were not yet convinced about the financial profile at the time.

"Puracon filed for insolvency in 2015, and we were able to invest within around four weeks, acquiring it from the administrator. We were able to keep the company's validations business and to convince the customers to stick with us."

SHS took steps to ensure the company's growth, Alilovic said: "We brought in a new management team, who did a good job in turning around the company, stabilising it and amending the culture, reducing the dependency on single customers. The company has seen growth of 25-30% per year, as well as double-digit EBITDA."

Asked about the timing of the exit, Alilovic said: "We had some inbound interest, mostly from strategics with PE sponsors, who saw the company as being ideally positioned to add innovation and profitable growth. We also had inbound interest from PE." The business saw interest from companies in the US, France and Germany.

SHS expects to announce more exits in the coming months, Alilovic said, having seen significant interest. "This is our third exit of the year – we have signed our fourth one and are waiting for the closing conditions. We also have some ongoing exit discussions, some of which are quite far advanced. A lot of PE-backed companies are looking at our portfolio for add-on opportunities. So we could have another exit in 2020, and more to come in H1 2021."

"We have done five platform investments in 2020, and we are now looking to invest in three to four Mittelstand growth companies," Alilovic added. "We are looking to raise the next fund and might start this at the end of 2021." The GP is currently deploying equity via SHS V Fonds, which held a final close in July 2019 on €130m.

Previous funding
In August 2013, BayBG acquired a minority stake in Puracon, with the intention to act as a silent partner for the business.

Company
Founded in 2003 and based in Rosenheim, Puracon cleans, packages and sterilises medical products, focusing on implants and instruments. The company reports revenues of less than €10m and has 70 employees.

People
SHS
– Sascha Alilovic (managing partner).
IK Investment Partners
– Anders Petersson (partner).
Puracon
– Ruth Gessner (managing director).
Klingel Medical Metal
– Ralf Petrawitz (CEO).

Advisers
Vendor
– Orrick (legal); Carlsquare (corporate finance).
Equity
– Renzenbrink & Partner (legal, tax); Ebner Stolz (corporate finance).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • Portfolio management
  • DACH
  • Healthcare
  • Germany
  • Build-up
  • IK Investment Partners

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013